Understanding the complexity of Miller-Fisher syndrome: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20244156Keywords:
Antiganglioside antibody, Immunotherapy, Miller-Fisher syndromeAbstract
Miller-Fisher syndrome is a rare neurological disorder characterized by a clinical trial of ophthalmoplegia, ataxia and areflexia. It is a variant of Gullian Barrie syndrome. A variety of other symptoms and signs beyond the triad has been reported. Here we report a case of a 58-year-old male patient with atypical presentation of Miller-Fisher syndrome. He had a history of upper respiratory tract infection 3 weeks prior. After hospital admission, he abruptly developed unsteadiness while walking, diplopia and dysphagia. Clinical evaluation along with antiganglioside antibody made the diagnosis of Miller-Fisher syndrome. After immunotherapy was initiated, the patient improved gradually and later discharged to home. To diagnose a case of Miller-Fisher syndrome, a high index of clinical suspicion and ruling out other aetiologies should be made. Timely effective intervention either plasmapheresis or IV Immunoglobulin can completely reverse the symptoms.
Metrics
References
Nachamkin I, Allos BM, Ho T. Campylobacter species and Guillain-Barre syndrome. Clin Microbiol Rev. 1998;11:555-67.
Roberts M, Vincent A, Newsom-Davis J, et al. Serum Factor in Miller-Fisher Variant of Guillain-Barré syndrome and neurotransmitter release. The Lancet. 1994;343(8895):454-5.
Muñiz AE. Multiple cranial nerve neuropathies, ataxia and, areflexia: Miller-Fisher syndrome in a child and review. Am J Emerg Med. 2017;35(4):661.
Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serumanti-GQ1bIgGantibody is associated with ophthalmoplegia in Miller-Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurol. 1917;247:720–1.
Chae CS, Kwon KM, Lee JS, Kim YH. A case report of overlapping Miller-Fisher syndrome, Guillain-Barre syndrome and the Bickerstaff brainstem encephalitis. Neurologist. 2018;23(4):128-30.
Bukhari S, Taboada J. A case of Miller-Fisher syndrome and literature review. Cureus. 2017;22;9(2):1048.
Chiba A, Kusunoki S, Shimizu T. Serumigg Antibody to Ganglioside GQ1b is a Possible Marker of Miller-Fisher Syndrome. Ann Neurol. 1992;31:677–9.
Yuki N, Sato S, Tsuji S. Frequent Presence Ofanti GQ1b Antibody in Fisher’s Syndrome. Neurol. 1993;43:414–7.
Doo-Hyuk K, Jung-Im S, Woo-Ho H, Dong-Kuck L: Clinical and electrophysiological characteristics of delayed facial palsy in Miller-Fisher syndrome. Korean J Clin Neurophysiol. 2011;13:44-7.